Breast Biopsy Devices Market 2025 to 2034
Breast Biopsy Devices Market 2025 to 2034
Breast Biopsy Devices Market (By Product: Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Others; By Guidance: Image-Guided Biopsy, Mammography-guided Stereotactic Biopsy, Ultrasound-guided Biopsy, MRI-guided Biopsy, Other Guidance Techniques, Liquid Biopsy, NGS-based Biopsy, PCR-based Biopsy, Microarray-based Biopsy; By Type) Industry Size, Share, Growth, Trends 2025 to 2034.
Customisation Request
Revenue, 2025
USD 1.13 Bn
Forecast Year, 2034
USD 1.64 Bn
CAGR, 2025 - 2034
4.17%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global breast biopsy devices market, valued at USD 1.13B in 2025, is projected to reach USD 1.64B by 2034, growing at a CAGR of 4.17%, driven by rising breast cancer incidence and adoption of minimally invasive diagnostic technologies.
Breast Biopsy Devices Market Size Analysis
Breast Biopsy Devices Market Size By Product 2025 to 2034 (USD Billion)
| Product | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Biopsy Needles | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | 0.06 |
| Guidance Systems | 0.08 | 0.09 | 0.09 | 0.09 | 0.10 | 0.10 | 0.10 | 0.11 | 0.11 | 0.12 |
| Biopsy Tables | 0.12 | 0.13 | 0.13 | 0.14 | 0.14 | 0.15 | 0.16 | 0.16 | 0.17 | 0.18 |
| Localization Wires | 0.16 | 0.17 | 0.18 | 0.18 | 0.19 | 0.20 | 0.21 | 0.22 | 0.22 | 0.23 |
| Assay Kits | 0.20 | 0.21 | 0.22 | 0.23 | 0.24 | 0.25 | 0.26 | 0.27 | 0.28 | 0.29 |
| Liquid Biopsy Instruments | 0.24 | 0.25 | 0.26 | 0.27 | 0.29 | 0.30 | 0.31 | 0.32 | 0.34 | 0.35 |
| Others | 0.28 | 0.29 | 0.31 | 0.32 | 0.33 | 0.35 | 0.36 | 0.38 | 0.39 | 0.41 |
Breast Biopsy Devices Market Size By Guidance 2025 to 2034 (USD Billion)
| Guidance | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Image-Guided Biopsy | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 |
| Mammography-guided Stereotactic Biopsy | 0.05 | 0.05 | 0.06 | 0.06 | 0.06 | 0.06 | 0.07 | 0.07 | 0.07 | 0.07 |
| Ultrasound-guided Biopsy | 0.08 | 0.08 | 0.08 | 0.09 | 0.09 | 0.09 | 0.10 | 0.10 | 0.11 | 0.11 |
| MRI-guided Biopsy | 0.10 | 0.11 | 0.11 | 0.11 | 0.12 | 0.12 | 0.13 | 0.13 | 0.14 | 0.15 |
| Other Guidance Techniques | 0.13 | 0.13 | 0.14 | 0.14 | 0.15 | 0.15 | 0.16 | 0.17 | 0.17 | 0.18 |
| Liquid Biopsy | 0.15 | 0.16 | 0.16 | 0.17 | 0.18 | 0.19 | 0.19 | 0.20 | 0.21 | 0.22 |
| NGS-based Biopsy | 0.18 | 0.18 | 0.19 | 0.20 | 0.21 | 0.22 | 0.23 | 0.23 | 0.24 | 0.25 |
| PCR-based Biopsy | 0.20 | 0.21 | 0.22 | 0.23 | 0.24 | 0.25 | 0.26 | 0.27 | 0.28 | 0.29 |
| Microarray-based Biopsy | 0.23 | 0.23 | 0.24 | 0.26 | 0.27 | 0.28 | 0.29 | 0.30 | 0.31 | 0.33 |
Breast Biopsy Devices Market Size By Type 2025 to 2034 (USD Billion)
| Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Needle Breast Biopsy | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 |
| Core Needle Biopsy (CNB) | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 |
| Fine Needle Aspiration Biopsy (FNAB) | 0.05 | 0.05 | 0.06 | 0.06 | 0.06 | 0.06 | 0.07 | 0.07 | 0.07 | 0.07 |
| Vacuum-assisted Biopsy (VAB) | 0.07 | 0.07 | 0.08 | 0.08 | 0.08 | 0.08 | 0.09 | 0.09 | 0.10 | 0.10 |
| Open Surgical Breast Biopsy | 0.09 | 0.09 | 0.09 | 0.10 | 0.10 | 0.11 | 0.11 | 0.11 | 0.12 | 0.12 |
| Excisional | 0.10 | 0.11 | 0.11 | 0.12 | 0.12 | 0.13 | 0.13 | 0.14 | 0.14 | 0.15 |
| Incisional | 0.12 | 0.13 | 0.13 | 0.14 | 0.14 | 0.15 | 0.15 | 0.16 | 0.17 | 0.17 |
| Liquid Breast Biopsy | 0.14 | 0.14 | 0.15 | 0.15 | 0.16 | 0.17 | 0.18 | 0.18 | 0.19 | 0.20 |
| Circulating Tumor Cells | 0.15 | 0.16 | 0.17 | 0.17 | 0.18 | 0.19 | 0.20 | 0.21 | 0.21 | 0.22 |
| Circulating Tumor DNA (CtDNA) | 0.17 | 0.18 | 0.19 | 0.19 | 0.20 | 0.21 | 0.22 | 0.23 | 0.24 | 0.25 |
| Other Biomarkers | 0.19 | 0.20 | 0.20 | 0.21 | 0.22 | 0.23 | 0.24 | 0.25 | 0.26 | 0.27 |
Breast Biopsy Devices Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.08 | 0.08 | 0.08 | 0.09 | 0.09 | 0.10 | 0.10 | 0.10 | 0.11 | 0.11 |
| Europe | 0.15 | 0.16 | 0.17 | 0.17 | 0.18 | 0.18 | 0.19 | 0.20 | 0.21 | 0.22 |
| Asia Pacific | 0.23 | 0.24 | 0.25 | 0.26 | 0.27 | 0.28 | 0.29 | 0.30 | 0.31 | 0.33 |
| Latin America | 0.30 | 0.31 | 0.33 | 0.34 | 0.35 | 0.37 | 0.38 | 0.40 | 0.42 | 0.44 |
| Middle East and Africa | 0.38 | 0.39 | 0.41 | 0.42 | 0.44 | 0.46 | 0.48 | 0.50 | 0.52 | 0.54 |
Breast Biopsy Devices Market Size to Surpass USD 1.64 Billion by 2034
The global breast biopsy devices market size was evaluated at USD 1.13 billion in 2025 and is expected to grow around USD 1.64 billion by 2034 a CAGR of 4.17%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
